Papers using
chromogranin A
antibodies
Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidationHerzog Herbert et al., In Cell Metabolism, 2009
... (Chemicon, Harrow, UK), DAPI (Sigma-Aldrich, Poole, UK), PGP9.5 (Ultraclone Ltd., Isle of Wight, UK), and chromogranin A (DAKO A/S, Glostrup, Denmark) were ... A case of primary small cell carcinoma of the breastBergkvist Leif et al., In Pathology Research International, 2006
... CD99 (Dako, clone 12E7, 1 : 100), NSE (Dako, clone BBS/NC/VIH14, 1 : 500), synaptophysin (Novocastra, clone 27G12, 1 : 150), chromogranin A (Dako, clone DAK-A3, 1 : 3000), high ... The gastric cardia: fact or fiction?Waldum Helge L. et al., In Gastroenterology Research and Practice, 1999
... Glostrup, Denmark, 1 : 200) and HDC (Code B260-1, Eurodiagnostica, 1 : 15000) for 1 hour at room temperature, and CgA (Code MO869, Dakocytomation, 1 : 2000) and serotonin (Code 6336, Abcam, 1 : 100) for 18 hours ... more suppliers
Papers on
chromogranin A
Chromogranin A: any relevance in neuroendocrine tumors?Modlin et al., New Haven, United States. In Curr Opin Endocrinol Diabetes Obes, Feb 2016
PURPOSE OF REVIEW: The review summarizes the utility and limitations of chromogranin A (CgA) as a circulating biomarker for neuroendocrine tumors (NETs).
Microcystic/Reticular Schwannoma of the Mandible First Case Report and Review of the Literature.Wu et al., Shanghai, China. In Medicine (baltimore), Nov 2015
Tumor cells were also positive for CD34, CD99, and NSE, but negative for CK, EMA, CK5/6, P63, Calponin, CD10, SMA, Desmin, GFAP, NF, Syn, and CgA.
The extended granin family: structure, function, and biomedical implications.Salton et al., Minneapolis, United States. In Endocr Rev, 2011
The chromogranins (chromogranin A and chromogranin B), secretogranins (secretogranin II and secretogranin III), and additional related proteins (7B2, NESP55, proSAAS, and VGF) that together comprise the granin family subserve essential roles in the regulated secretory pathway that is responsible for controlled delivery of peptides, hormones, neurotransmitters, and growth factors.
Chromogranin A is an autoantigen in type 1 diabetes.Haskins et al., Denver, United States. In Nat Immunol, 2010
In the nonobese diabetic (NOD) mouse model of type 1 diabetes, we have identified the peptide WE14 from chromogranin A (ChgA) as the antigen for highly diabetogenic CD4(+) T cell clones.
More papers using
chromogranin A
antibodies